Niki BioSolutions director reports 1,062-share holding

Niki BioSolutions, Inc. reports the initial equity position of director Arner Douglas Wayne.

Rhea-AI Filing Summary

Niki BioSolutions, Inc. reports the initial equity position of director Arner Douglas Wayne. As of 2026-07-20, he is shown as directly holding 1,062 shares of the company’s Common Stock. This filing establishes his baseline beneficial ownership stake as a board member.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Arner Douglas Wayne

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,062 shares (Direct)

Key Figures

Common Stock holding: 1,062 shares

1 metrics

Common Stock holding 1,062 shares Directly owned by director Arner Douglas Wayne as of 2026-07-20

Key Terms

beneficial ownership, Common Stock, direct ownership

3 terms

beneficial ownership financial

"This filing establishes his baseline beneficial ownership stake as a board member."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Common Stock financial

"he is shown as directly holding 1,062 shares of the company’s Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

direct ownership financial

"The Form 3 lists Wayne’s current direct holding of 1,062 common shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider ownership did NIKI director Arner Douglas Wayne report?

Arner Douglas Wayne reported beneficial ownership of 1,062 shares of Niki BioSolutions, Inc. Common Stock, held directly. This Form 3 filing establishes his initial reported equity stake as a member of the company’s board of directors.

Does the NIKI Form 3 show any recent insider buying or selling?

No specific buy or sell transaction is reported. The Form 3 lists Wayne’s current direct holding of 1,062 common shares, serving as an initial ownership statement rather than documenting a particular purchase or sale.

What type of security does Arner Douglas Wayne hold in NIKI?

Arner Douglas Wayne holds Common Stock of Niki BioSolutions, Inc. The filing shows a direct position of 1,062 shares, with no derivative securities such as options or warrants listed in this report.

Is Arner Douglas Wayne a director or officer of Niki BioSolutions (NIKI)?

Arner Douglas Wayne is identified as a director of Niki BioSolutions, Inc. He is not reported as an officer in this filing and has no officer title listed, indicating his role is on the company’s board.

How are Arner Douglas Wayne’s NIKI shares characterized in the Form 3?

His 1,062 Niki BioSolutions shares are reported as directly owned. The ownership code is “D,” indicating personal direct ownership rather than indirect holdings through a trust, fund, or other entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Arner Douglas Wayne

(Last) (First) (Middle)

C/O NIKI BIOSOLUTIONS, INC.

116 VILLAGE BOULEVARD, SUITE 200

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2026

3. Issuer Name and Ticker or Trading Symbol
Niki BioSolutions, Inc. [ NIKI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,062	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Douglas W. Arner	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)